The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Bench-to-bedside imaging in brain metastases: a road to precision oncology
Open accessAbstract
Radiology has seen tremendous evolution in the last few decades. At the same time, oncology has made great strides in diagnosing and treating cancer. Distant metastases of neoplasms are being encountered more often in light of longer patient survival due to better therapeutic strategies and diagnostic methods. Brain metastasis (BM) is a dismal manifestation of systemic cancer. In the present scenario, magnetic resonance imaging (MRI), computed tomography (CT) and positron emission tomography (PET) are playing a big role in providing molecular information about cancer. Lately, molecular imaging has emerged as a stirring arena of dynamic imaging techniques that have enabled clinicians and scientists to noninvasively visualize and understand biological processes at the cellular and molecular levels. This knowledge has impacted etiopathogenesis, detection, personalized treatment, drug development, and our understanding of carcinogenesis. This article offers insight into the molecular biology underlying brain metastasis, its pathogenesis, imaging protocols, and algorithms. It also discusses disease-specific molecular imaging features, focusing on common tumors that spread to the brain, such as lung, breast, colorectal cancer, melanoma, and renal cell carcinoma. Additionally, it covers various targeted treatment options, criteria for assessing treatment response, and the role of artificial intelligence in diagnosing, managing, and predicting prognosis for patients with brain metastases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Despite these potential benefits, the deployment of digital tools for both healthcare and research purposes has proven challenging. Few have had success at securing regulatory approval for use, 2 and none have yet had a significant impact on either patient management or candidate therapeutic evaluation.”
From Developing digital health technologies for frontotemporal degeneration (2025) · cites this paper as [2]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
A molecular signature of metastasis in primary solid tumors
Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2002) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,469
Epidemiology of Brain Metastases
Nayak, L., Lee, E. Q., & Wen, P. Y. (2011) · Current Oncology Reports · doi:10.1007/s11912-011-0203-y · Cited by 1,369
Bendell, J. C., Domchek, S. M., Burstein, H. J., Harris, L. N., Younger, J., Kuter, I., Bunnell, C. A., Rué, M., Gelman, R. S., & Winer, E. P. (2003) · Cancer · doi:10.1002/cncr.11436 · Cited by 1,318
Prognostic markers in triple‐negative breast cancer
Rakha, E. A., El‐Sayed, M. E., Green, A. R., Lee, A. H. S., Robertson, J. F. R., & Ellis, I. O. (2006) · Cancer · doi:10.1002/cncr.22381 · Cited by 1,284
Lei, S., Zheng, R., Zhang, S., Wang, S., Chen, R., Sun, K., Zeng, H., Zhou, J., & Wei, W. (2021) · 癌症：英文版 · doi:10.1002/cac2.12207 · Cited by 1,210
Response assessment criteria for brain metastases: proposal from the RANO group
Lin, N., Lee, E. Q., Aoyama, H., Barani, I. J., Barboriak, D. P., Baumert, B. G., Bendszus, M., Brown, P. D., Camidge, D. R., Chang, S. M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70057-4 · Cited by 1,099
Brain metastases: epidemiology and pathophysiology
Gavrilovic, I. T., & Posner, J. B. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-8093-6 · Cited by 1,007
Cagney, D. N., Martin, A. M., Catalano, P. J., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox077 · Cited by 870
Distribution of Brain Metastases
Delattre, J., Krol, G. S., Thaler, H. T., & Posner, J. B. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520310047016 · Cited by 779
Bensch, F., van der Veen, E. L., Hooge, M. N. L., Jorritsma‐Smit, A., Boellaard, R., Kok, I. C., Oosting, S. F., Schroder, C. P., Hiltermann, T. J. N., van der Wekken, A. J., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0255-8 · Cited by 749
Neurosurgical Outcomes in a Modern Series of 400 Craniotomies for Treatment of Parenchymal Tumors
Sawaya, R. A., Hammoud, M. A., Schoppa, D., Hess, K. R., Wu, S. Z., Shi, W. M., & WiIdrick, D. M. (1998) · Neurosurgery · doi:10.1097/00006123-199805000-00054 · Cited by 645
Rhun, É. L., Gückenberger, M., Smits, M., Dummer, R., Bachelot, T., Sahm, F., Galldiks, N., de Azambuja, E., Berghoff, A. S., Métellus, P., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.07.016 · Cited by 607
Current approaches to the management of brain metastases
Suh, J. H., Kotecha, R. R., Chao, S. T., Ahluwalia, M. S., Sahgal, A., & Chang, E. L. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0320-3 · Cited by 570
Law, M., Cha, S., Knopp, E. A., Johnson, G., Arnett, J., & Litt, A. W. (2002) · Radiology · doi:10.1148/radiol.2223010558 · Cited by 566
Patterns of Contrast Enhancement in the Brain and Meninges
Smirniotopoulos, J. G., Murphy, F. M., Rushing, E. J., Rees, J., & Schroeder, J. W. (2007) · Radiographics · doi:10.1148/rg.272065155 · Cited by 503
Leptomeningeal metastases in the MRI era
Clarke, J. L., Perez, H. R., Jacks, L. M., Panageas, K. S., & DeAngelis, L. M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dc1a69 · Cited by 431
Oncogenic driver mutations in non-small cell lung cancer: Past, present and future
Chevallier, M., Borgeaud, M., Addeo, A., & Friedlaender, A. (2021) · World Journal of Clinical Oncology · doi:10.5306/wjco.v12.i4.217 · Cited by 339
Fink, K. R. T., & Fink, J. (2013) · Surgical Neurology International · doi:10.4103/2152-7806.111298 · Cited by 338
Kaplan, J. G., DeSouza, T. G., Farkash, A., Shafran, B., Pack, D. R., Rehman, F., Fuks, J. Z., & Portenoy, R. K. (1990) · Journal of Neuro-Oncology · doi:10.1007/bf02341153 · Cited by 309
Chiang, I., Kuo, Y., Lu, C., et al. (2004) · Neuroradiology · doi:10.1007/s00234-004-1246-7 · Cited by 283
Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors
Weber, M. D., Zoubaa, S., Schlieter, M., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000219767.49705.9c · Cited by 268
Chamberlain, M. C., Sandy, A. D., & Press, G. A. (1990) · Neurology · doi:10.1212/wnl.40.3_part_1.435 · Cited by 267
Radiomics of Brain MRI: Utility in Prediction of Metastatic Tumor Type
Kniep, H. C., Madesta, F., Schneider, T., Hanning, U. M. P., Schönfeld, M. H., Schön, G., Fiehler, J., Gauer, T., Werner, R., & Gellißen, S. (2018) · Radiology · doi:10.1148/radiol.2018180946 · Cited by 234
Brain metastases: neuroimaging
Pope, W. B. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-12-811161-1.00007-4 · Cited by 226
Survival of breast cancer patients with meningeal carcinomatosis
Gauthier, H., Guilhaume, M. N., Bidard, F., Pierga, J., Girre, V., Cottu, P. H., Laurence, V., Livartowski, A., Mignot, L., & Dieras, V. C. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq232 · Cited by 184
Rollin, N., Guyotat, J., Streichenberger, N., et al. (2006) · Neuroradiology · doi:10.1007/s00234-005-0030-7 · Cited by 182
Intracerebral malignant melanoma: high-field-strength MR imaging.
Woodruff, W. W., Djang, W. T., McLendon, R. E., et al. (1987) · Radiology · doi:10.1148/radiology.165.1.3628773 · Cited by 171
Dural masses: meningiomas and their mimics
Lyndon, D., Lansley, J., Evanson, J., et al. (2019) · Insights into Imaging · doi:10.1186/s13244-019-0697-7 · Cited by 167
Differentiation between glioblastoma, brain metastasis and subtypes using radiomics analysis
Artzi, M., Bressler, I., & Bashat, D. B. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26643 · Cited by 165
Nayak, L., Abrey, L. E., & IWAMOTO, F. M. (2009) · Cancer · doi:10.1002/cncr.24203 · Cited by 161
Tsougos, I., Svolos, P., Kousi, E., Fountas, K. N., Theodorou, K., Fezoulidis, I. V., & Kapsalaki, E. Z. (2012) · Cancer Imaging · doi:10.1102/1470-7330.2012.0038 · Cited by 160
Werner‐Wasik, M., Scott, C., Nelson, D. F., Gaspar, L. E., Murray, K. J., Fischbach, J. A., Nelson, J. S., Weinstein, A. S., & Curran, W. J. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960415)77:8 · Cited by 153
MR imaging of leptomeningeal metastases: comparison of three sequences.
Singh, S. K., Leeds, N. E., & Ginsberg, L. E. (2002) · PubMed · Cited by 150
Prognostic significance of sup 111 Indium-DTPA CSF flow studies in leptomeningeal metastases
Chamberlain, M. C., & Kormanik, P. A. (1996) · Neurology · doi:10.1212/wnl.46.6.1674 · Cited by 148
Clinical applications of artificial intelligence and radiomics in neuro-oncology imaging
Razek, A. A. K. A., Alksas, A., Shehata, M., AbdelKhalek, A., Abdel-Baki, K., El-Baz, A. S., & Helmy, E. M. (2021) · Insights into Imaging · doi:10.1186/s13244-021-01102-6 · Cited by 148
Symptoms and the early diagnosis of lung cancer
Birring, S. (2005) · Thorax · doi:10.1136/thx.2004.032698 · Cited by 141
Hemangiopericytoma of the Meninges: Mayo Clinic Experience
Goellner, J. R., Laws, E. R., Soule, E. H., et al. (1978) · American Journal of Clinical Pathology · doi:10.1093/ajcp/70.3.375 · Cited by 140
Server, A., Josefsen, R., Kulle, B., et al. (2010) · Acta Radiologica · doi:10.3109/02841850903482901 · Cited by 136
Smith, A. B., Horkayne‐Szakaly, I., Schroeder, J. W., & Rushing, E. J. (2014) · Radiographics · doi:10.1148/rg.342130075 · Cited by 135
Primary Low-Grade B-Cell Lymphoma of the Dura
Kumar, S., Kumar, D., Kaldjian, E. P., et al. (1997) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199701000-00009 · Cited by 133
Server, A., Kulle, B., Mæhlen, J., et al. (2009) · Acta Radiologica · doi:10.1080/02841850902933123 · Cited by 126
Secondary Neoplasms of the Central Nervous System and Meninges
Meyer, P. C., & Reah, T. G. (1953) · British Journal of Cancer · doi:10.1038/bjc.1953.44 · Cited by 120
Merrill, R. M., Capocaccia, R., Feuer, E. J., et al. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.2.197 · Cited by 117
Weisman, P. S., Ng, C. K. Y., Brogi, E., Eisenberg, R. E. K., Won, H. H., Piscuoglio, S., Filippo, M. R. D., Ioris, R. A., Akram, M. M., Norton, L., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.39 · Cited by 115
Ahn, J. H., Lee, S. H., Kim, S., Joo, J., Yoo, H., Lee, S., Shin, S. H., & Gwak, H. (2012) · Journal of neurosurgery · doi:10.3171/2012.1.jns111560 · Cited by 113
A Review of Epidemiology and Cancer Biology of Malignant Melanoma
Davey, M. G., Miller, N., & McInerney, N. M. (2021) · Cureus · doi:10.7759/cureus.15087 · Cited by 111
Friedman, D. P. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.185.2.01850563 · Cited by 94
Epidemiology of synchronous brain metastases
Singh, R. B., Stoltzfus, K. C., Chen, H., Louie, A. V., Lehrer, E. J., Horn, S. R., Palmer, J. D., Trifiletti, D. M., Brown, P. D., & Zaorsky, N. G. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa041 · Cited by 94
High‐dose gadoteridol in MR imaging of intracranial neoplasms
Runge, V. M., KIRSCH, J. E., Burke, V. J., Price, A. C., Nelson, K. L., Thomas, G. S., Dean, B. L., & Lee, C. (1992) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880020103 · Cited by 90
Åkeson, P., Larsson, E.-M., Kristoffersen, D. T., et al. (1995) · Acta Radiologica · doi:10.1177/028418519503600318 · Cited by 89
Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases.
Yuh, W. T. C., Fisher, D. J., Runge, V. M., Atlas, S. W., Harms, S. E., Maravilla, K. R., Mayr, N. A., Mollman, J. E., & Price, A. C. (1994) · PubMed Central · Cited by 85
FLAIR MR Imaging for Diagnosing Intracranial Meningeal Carcinomatosis
Tsuchiya, K., Katase, S., Yoshino, A., & Hachiya, J. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.176.6.1761585 · Cited by 85
Lüdemann, L., Grieger, W., Wurm, R. E., et al. (2005) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2005.06.007 · Cited by 82
Kushnirsky, M., Nguyen, V., Katz, J. S., Steinklein, J. M., Rosen, L. M., Warshall, C., Schulder, M., & Knisely, J. P. S. (2015) · Journal of neurosurgery · doi:10.3171/2015.2.jns141993 · Cited by 81
Hemorrhagic neoplasms: MR mimics of occult vascular malformations
Sze, G. K., Krol, G. D., Olsen, W. L., et al. (1987) · American Journal of Roentgenology · doi:10.2214/ajr.149.6.1223 · Cited by 79
Frequency of unexplained meningeal enhancement in the brain after lumbar puncture.
Mittl, R. L., & Yousem, D. M. (1994) · PubMed · Cited by 77
Brain metastasis in lung cancer
Mottaghy, F. M., Buck, A. K., Maschke, S., Kley, H., Frechen, D., Wibmer, T., Reske, N. S., Pauls, S., & Krüger, S. (2010) · Nuklearmedizin - NuclearMedicine · doi:10.3413/nukmed-0338-10-07 · Cited by 73
Leenders, W. P. J., Küsters, B., Pikkemaat, J. A., Wesseling, P., Ruiter, D. J., Heerschap, A., Barentsz, J. O., & de Waal, R. M. W. (2003) · International Journal of Cancer · doi:10.1002/ijc.11102 · Cited by 71
Kremer, S., Grand, S., Berger, F. F., et al. (2003) · Neuroradiology · doi:10.1007/s00234-002-0886-8 · Cited by 68
Zakaria, R., Das, K., Radon, M. R., et al. (2014) · BMC Medical Imaging · doi:10.1186/1471-2342-14-26 · Cited by 67
Kleinschmidt-DeMasters, B. K. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-0880-dm · Cited by 67
Sunwoo, L., Yun, T. J., You, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166662 · Cited by 66
Clatot, F., Philippin-Lauridant, G., Ouvrier, M.-J., Nakry, T., Laberge, S., Guillemet, C., Veyret, C., & Blot, E. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9940-2 · Cited by 61
Bernards, R. (2003) · Nature · doi:10.1038/425247a · Cited by 55
Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumine
Balériaux, D. F., Colosimo, C., Ruscalleda, J., et al. (2002) · Neuroradiology · doi:10.1007/s002340100636 · Cited by 51
Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer
Fowler, A. M., Clark, A. S., Katzenellenbogen, J. A., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.157933 · Cited by 49
18F-FET PET Uptake Characteristics in Patients with Newly Diagnosed and Untreated Brain Metastasis
Unterrainer, M., Galldiks, N., Suchorska, B., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.180075 · Cited by 49
Mishima, Y., Imahori, Y., HONDA, C., et al. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005746020350 · Cited by 46
Cerebral Melanoma Metastases: A Critical Review on Diagnostic Methods and Therapeutic Options
Goulart, C. R., Mattei, T. A., & Ramina, R. (2011) · ISRN Surgery · doi:10.5402/2011/276908 · Cited by 40
Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms
Kravchenko, J. S., Akushevich, I. V., Seewaldt, V. L., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1347-z · Cited by 40
Incidence and Predictive Factors for Pulmonary Metastases After Curative Resection of Colon Cancer
Watanabe, K., Saito, N., Sugito, M., Ito, M., Kobayashi, A., & Nishizawa, Y. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2747-y · Cited by 37
Guzman, R. G., Altrichter, S., El‐Koussy, M., et al. (2008) · Journal of Neuroradiology · doi:10.1016/j.neurad.2008.02.003 · Cited by 33
Lui, Y. W., Malhotra, A. D., Farinhas, J. M., et al. (2011) · American Journal of Roentgenology · doi:10.2214/ajr.10.5309 · Cited by 32
Bette, S. J., Huber, T. S., Wiestler, B., et al. (2016) · European Journal of Radiology · doi:10.1016/j.ejrad.2016.10.002 · Cited by 32
Review of Imaging Techniques in the Diagnosis and Management of Brain Metastases
Lignelli, A., & Khandji, A. G. (2010) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2010.09.002 · Cited by 29
Cohen‐Inbar, O., Xu, Z., Dodson, B. K., Rizvi, T., Durst, C. R., Mukherjee, S., & Sheehan, J. P. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2242-6 · Cited by 29
Methotrexate-induced posterior reversible encephalopathy syndrome
Aradillas, E., Arora, R., & Gasperino, J. (2010) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2010.01207.x · Cited by 28
Building the Bridge: Molecular Imaging Biomarkers for 21st Century Cancer Therapies
Sellmyer, M. A., Lee, I. K., & Mankoff, D. A. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.262484 · Cited by 27
Advanced magnetic resonance imaging biomarkers of cerebral metastases
Mills, S. J., Thompson, G., & Jackson, A. (2012) · Cancer Imaging · doi:10.1102/1470-7330.2012.0012 · Cited by 26
Internò, V., Santis, P. D., Stucci, L. S., et al. (2021) · Cancers · doi:10.3390/cancers13092114 · Cited by 24
Normal Variants, Pitfalls and Artifacts in Ga-68 DOTATATE PET/CT Imaging
Malan, N. T., & Vangu, M. D. T. H. W. (2022) · Frontiers in Nuclear Medicine · doi:10.3389/fnume.2022.825486 · Cited by 24
Gutierrez-Valencia, E., Sanchez-Rodriguez, I. E., Ricardo, B.-I., Jesus, F.-L., Alan, R.-M., Inigo, V. A. A., Luis, B.-L., Allan, H. C., Puebla‐Mora, A. G., Liliana, N.-R., et al. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2019.20 · Cited by 23
Qian, Y., Yu, C.-L., Zhang, C., et al. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0907 · Cited by 22
Widdel, L., Kleinschmidt-DeMasters, B. K., & Kindt, G. W. (2010) · World Neurosurgery · doi:10.1016/j.wneu.2010.01.021 · Cited by 21
Dormann, C. (2020) · Breast Care · doi:10.1159/000512328 · Cited by 20
Tomura, N., Narita, K., Takahashi, S., et al. (2007) · Acta Radiologica · doi:10.1080/02841850701499425 · Cited by 18
McGann, G., & Platts, A. (1991) · British Journal of Radiology · doi:10.1259/0007-1285-64-760-310 · Cited by 17
Brain metastases from breast cancer
Santos, J., Arantes, J., Carneiro, E., et al. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.106150 · Cited by 11
Can nonenhancing white matter lesions in cancer patients be disregarded?
Elster, A. D., & Chen, M. Y. M. (1992) · PubMed · Cited by 10
Computerized tomographic findings in intracranial metastatic malignant melanoma
Weisberg, L. A. (1985) · Computerized Medical Imaging and Graphics · doi:10.1016/0730-4862(85)90123-4 · Cited by 10
Increased Iofetamine I 123 Brain Uptake in Metastatic Melanoma
Nagel, J. S., Ichise, M., Müeller, S., et al. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520340080016 · Cited by 7
Research works printed but not linked: 4
- Merrill, 2000, Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program, International Journal of Epidemiology, 29, 197, 10.1093/ije/29.2.197 · DOI
- Savage, 2011, Dural-based metastatic carcinomas mimicking primary CNS neoplasia: report of 7 cases emphasizing the role of timely surgery and accurate pathologic evaluation, International Journal of Clinical and Experimental Pathology, 4, 530
- Altundag, 2007, Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis. Cancer, Interdisciplinary International Journal of the American Cancer Society, 110, 2640
- Blinded for review.
Cited by
Sorted by citations
Developing digital health technologies for frontotemporal degeneration
Nevler, N., Niehoff, D., Gleixner, A. M., Dodge, S., Vogel, A. P., Hill, D. L., Ducharme, S., Staffaroni, A. M., Yunusova, Y., Au, R., et al. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70082 · Cited by 7
Metadata
- Authors
- Shukla, S., Karbhari, A., Rastogi, S., Agarwal, U., Rai, P., & Mahajan, A.
- Affiliations
- Homi Bhabha National Institute (IN)
- University of Liverpool (GB)
- Corresponding author
- Mahajan, A.
- Venue
- Clinical Radiology
- Publisher
- Elsevier BV
- Published
- 2024-07
- Volume
- 79
- Issue
- 7
- Pages
- 485-500
- ISSN
- 0009-9260 (ISSN-L)
- OpenAlex
- W4392881614
- Cited by
- 12
- References
- 93
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 2
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Radiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Brain Metastases and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Keywords
- brain metastases, molecular imaging, precision oncology, lung cancer metastases, breast cancer metastasis, colorectal cancer metastasis, melanoma, renal cell carcinoma, treatment response assessment, AI-assisted diagnosis, imaging protocols
- MeSH terms
- Brain Neoplasms, Humans, Magnetic Resonance Imaging, Tomography, X-Ray Computed, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
